{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:38:04Z","timestamp":1771591084743,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.atherosclerosis.2023.117425","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:03:47Z","timestamp":1702332227000},"page":"117425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Differential effect of atorvastatin and pravastatin on thoracic spine attenuation: A sub-analysis of a randomized clinical trial"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-1948","authenticated-orcid":false,"given":"Paolo","family":"Raggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin M.","family":"Takyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varuna","family":"Gadiyaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur E.","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir H.","family":"Davarpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.117425_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tem.2022.02.001","article-title":"Lipids and lipoproteins in cardiovascular diseases: a classification","volume":"33","author":"Bhargava","year":"2022","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","article-title":"Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting","volume":"159","author":"Soppert","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/JBMR.050711","article-title":"Relationship between osteoporosis and cardiovascular disease in postmenopausal women","volume":"20","author":"Tank\u00f3","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-006-0052-0","article-title":"Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the Health, Aging, and Body Composition Study","volume":"79","author":"Farhat","year":"2006","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00198-007-0338-8","article-title":"The association of bone mineral density measures with incident cardiovascular disease in older adults","volume":"18","author":"Farhat","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstr\u00f6m","year":"2020","journal-title":"Arch. Osteoporosis"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"Compston","year":"2019","journal-title":"Osteoporosis. Lancet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117425_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023085","article-title":"Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews","volume":"9","author":"Byrne","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib9","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar413","article-title":"The role of statins as potential targets for bone formation","volume":"4","author":"Garrett","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib12","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","article-title":"Oral statins and increased bone-mineral density in postmenopausal women","volume":"355","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib14","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib15","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","article-title":"HMG-CoA reductase inhibitors and the risk of fractures","volume":"283","author":"Meier","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib16","first-page":"1137","article-title":"HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients","volume":"85","author":"Chung","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.164.2.146","article-title":"Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials","volume":"164","author":"Bauer","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/CIRCULATIONAHA.104.512681","article-title":"Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT Scanning (BELLES)","volume":"112","author":"Raggi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2015.02.072","article-title":"High dose and long-term statin therapy accelerate coronary artery calcification","volume":"184","author":"Henein","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00198-016-3724-2","article-title":"Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment","volume":"28","author":"Kim","year":"2017","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00004728-200401000-00023","article-title":"Measurement of trabecular bone mineral density in the thoracic spine using cardiac gated quantitative computed tomography","volume":"28","author":"Lenchik","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.acra.2013.01.007","article-title":"Noncontrast cardiac computed tomography image-based vertebral bone mineral density: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"20","author":"Li","year":"2013","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/bbrc.2000.2697","article-title":"Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells","volume":"271","author":"Sugiyama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","article-title":"The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity","volume":"18","author":"Staal","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00198-016-3844-8","article-title":"Efficacy of statins for osteoporosis: a systematic review and meta-analysis","volume":"28","author":"An","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jamda.2019.06.027","article-title":"Effects of statins on relative risk of fractures for older adults: an updated systematic review with meta-analysis","volume":"20","author":"Shi","year":"2019","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/CLEP.S145311","article-title":"High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study","volume":"10","author":"Lin","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib30","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1210\/jc.2006-1909","article-title":"Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial","volume":"92","author":"Bone","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib31","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2019-215714","article-title":"Diagnosis of osteoporosis in statin-treated patients is dose-dependent","volume":"78","author":"Leutner","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib32","article-title":"Low dose hydrophilic statins are the preferred agents for females at risk of osteoporosis","volume":"16","author":"Antonenko","year":"2022","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-015-3416-3","article-title":"Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men","volume":"27","author":"Kuipers","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00223-010-9427-3","article-title":"Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea","volume":"87","author":"Jeong","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib35","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jbmr.3989","article-title":"The effect of plasma lipids and lipid\u2010lowering interventions on bone mineral density: a Mendelian randomization study","volume":"35","author":"Zheng","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bone.2019.05.037","article-title":"Causal link between lipid profile and bone mineral density: a Mendelian randomization study","volume":"127","author":"Yang","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/1871530318666180423122409","article-title":"Identifying potential therapeutics for osteoporosis by exploiting the relationship between mevalonate pathway and bone metabolism","volume":"18","author":"Hasan","year":"2018","journal-title":"Endocr., Metab. Immune Disord.: Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/71484","article-title":"Statins: lower lipids and better bones?","volume":"6","author":"Rogers","year":"2000","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2023.117425_bib39","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","article-title":"Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women","volume":"61","author":"Alexopoulos","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013104","article-title":"Statins reduce epicardial adipose tissue attenuation independent of lipid lowering: a potential pleiotropic effect","volume":"8","author":"Raggi","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib41","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1210\/jc.2008-2422","article-title":"Reciprocal relations of subcutaneous and visceral fat to bone structure and strength","volume":"94","author":"Gilsanz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12020-016-0945-2","article-title":"Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly","volume":"53","author":"Valassi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/14017431.2019.1659397","article-title":"Osteocalcin and epicardial adipose tissue in obesity: new hints for epicardial adipose tissue\u2013bone crosstalk","volume":"53","author":"Yaylali","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115542","article-title":"The role of bone morphogenetic protein signaling in vascular calcification","volume":"141","author":"Yang","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.numecd.2022.12.006","article-title":"Association between coronary artery calcium and thoracic spine bone mineral density: multiethnic Study of Atherosclerosis (MESA)","volume":"33","author":"Manubolu","year":"2023","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib47","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/ijerph17061862","article-title":"How physical activity across the lifespan can reduce the impact of bone ageing: a literature review","volume":"17","author":"Faienza","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib48","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1249\/01.MSS.0000142662.21767.58","article-title":"American college of sports medicine. American college of sports medicine position stand: physical activity and bone health","volume":"36","author":"Kohrt","year":"2004","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/jc.2018-02054","article-title":"Association between cortical bone microstructure and statin use in older women","volume":"104","author":"Larsson","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40634-016-0072-2","article-title":"Quantitative computed tomography (QCT) derived bone mineral density (BMD) in finite element studies: a review of the literature","volume":"3","author":"Knowles","year":"2016","journal-title":"J Exp Orthop"},{"key":"10.1016\/j.atherosclerosis.2023.117425_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110001","article-title":"Sources of error in bone mineral density estimates from quantitative CT","volume":"144","author":"Brunnquell","year":"2021","journal-title":"Eur. J. Radiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023053467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023053467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:53:35Z","timestamp":1758156815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023053467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"alternative-id":["S0021915023053467"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117425","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of atorvastatin and pravastatin on thoracic spine attenuation: A sub-analysis of a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117425"}}